Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
2.
Patel TR, McHugh BJ, Bi WL, et al. A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol. 2011;32(10):1885–92.CrossRef
3.
Menoux I, Armspach JP, Noel G, et al. Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: literature review. Cancer Radiother. 2016;20(8):837–45.CrossRef
4.
O'Beirn M, Benghiat H, Meade S, et al. The Expanding role of radiosurgery for brain metastases. Medicines (Basel). 2018;5(3).
5.
Churilla TM, Chowdhury IH, Handorf E, et al. Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2019;5(2):243–7.CrossRef
6.
Rades D, Pluemer A, Veninga T, et al. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer. 2007;110(10):2285–92.CrossRef
7.
Schimmel WCM, Gehring K, Eekers DBP, et al. Cognitive effects of stereotactic radiosurgery in adult patients with brain metastases: a systematic review. Adv Radiat Oncol. 2018;3(4):568–81.CrossRef
8.
Schillaci O, Calabria F, Tavolozza M, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun. 2010;31(1):39–45.CrossRef
9.
Beheshti M, Haroon A, Bomanji JB, et al. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls. PET Clin. 2014;9(3):299–306.CrossRef
10.
Wyss MT, Weber B, Honer M, et al. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging. 2004;31(3):312–6.CrossRef
11.
van Waarde A, Jager PL, Ishiwata K, et al. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006;47(1):150–4.PubMed
12.
Mertens K, Bolcaen J, Ham H, et al. The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study. Nucl Med Commun. 2012;33(9):954–9.CrossRef
13.
Bolcaen J, Lybaert K, Moerman L, et al. Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the fiscrimination between high-grade glioma and radiation necrosis in rats. PLoS One. 2016;11(8):e0161845.CrossRef
14.
Minniti G, Scaringi C, Paolini S, et al. Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys. 2016;95(4):1142–8.CrossRef
15.
Dirnagl U. The p value wars (again). Eur J Nucl Med Mol Imaging. 2019;46(12):2421–3.CrossRef
16.
Lohmann P, Kocher M, Ceccon G, et al. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis. Neuroimage Clin. 2018;20:537–42.CrossRef
17.
Peng L, Parekh V, Huang P, et al. Distinguishing true progression from Radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics. Int J Radiat Oncol Biol Phys. 2018;102(4):1236–43.CrossRef
Metadata
Title
Editorial commentary to “18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases” by Grkovski and colleagues
Authors
Pierre Lovinfosse
Selma Ben Mustapha
Nadia Withofs
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04651-7

Other articles of this Issue 6/2020

European Journal of Nuclear Medicine and Molecular Imaging 6/2020 Go to the issue

Correction

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

Letter to the Editor

Considerations on bone volume normalization in quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT

Original Article

Etiologic classification of infantile spasms using positron emission/magnetic resonance imaging and the efficacy of adrenocorticotropic hormone therapy

Image of the Month

FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma

Correction

Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes

Original Article

Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse